Roadzen Inc. entered into Placement Agency Agreement with Maxim Group LLC valued at 6.0% cash fee of aggregate gross proceeds and $30,000 expense reimbursement (effective 2026-05-04).
“On May 4, 2026, Roadzen Inc. (the "Company") entered into a placement agency agreement (the "Agency Agreement") with Maxim Group LLC (the "Placement Agent") and a securities purchase agreement (the "Purchase Agreement") with purchasers for the purchase and sale, in a best efforts offering (the "Offering"), of 4,705,870 of the Company’s ordinary shares, par value $0.0001 per share ("Ordinary Shares"), at an offering price of $1.70 per Share.”
Material Agreements
Roadzen Inc. entered into Securities Purchase Agreement with purchasers valued at 4,705,870 ordinary shares at $1.70 per share; gross proceeds of $7,999,979 (effective 2026-05-04).
“On May 4, 2026, Roadzen Inc. (the "Company") entered into a placement agency agreement (the "Agency Agreement") with Maxim Group LLC (the "Placement Agent") and a securities purchase agreement (the "Purchase Agreement") with purchasers for the purchase and sale, in a best efforts offering (the "Offering"), of 4,705,870 of the Company’s ordinary shares, par value $0.0001 per share ("Ordinary Shares"), at an offering price of $1.70 per Share.”
Material Agreements
Roadzen Inc. entered into Second Amendment to Securities Purchase Agreement and Junior Convertible Note with an institutional investor valued at Amendment to change installment dates to April 21, 2026 and May 21, 2026, and grant participation ri (effective 2026-02-25).
“On February 25, 2026, Roadzen Inc. (the “Company”) entered into a Second Amendment to Securities Purchase Agreement and Junior Convertible Note (the “Second Amendment”), which amended certain of the terms of (i) that certain Securities Purchase Agreement, dated as of November 20, 2025 (the “SPA”), entered into between the Company and an institutional investor (the “Investor”), and (ii) the junior convertible notes issued to the Investor in November 2025 (as previously amended, the “November Notes”) pursuant to the terms of the SPA, as described in the Current Report on Form 8-K filed by the Company on November 20, 2025.”
Material Agreements
Roadzen Inc. amended Amendment to Securities Purchase Agreement and Junior Convertible Note with Institutional Investor valued at Amends certain terms of junior convertible notes issued in November 2025 to add cross-default provis (effective 2026-01-20).
“On January 20, 2026, the Company and the Investor entered into an Amendment to Securities Purchase Agreement and Junior Convertible Note (the “Amendment”), which amended certain of the terms of the junior convertible notes issued to the Investor in November 2025 (the “November Notes”) pursuant to the terms of that certain Securities Purchase Agreement dated as of November 20, 2025, as described in the Current Report on Form 8-K filed by the Company on November 20, 2025.”
Material Agreements
Roadzen Inc. entered into Securities Purchase Agreement with Institutional Investor valued at Up to $5,555,555 principal amount of junior convertible notes, gross purchase price $5,000,000 (effective 2026-01-19).
“On January 19, 2026, Roadzen Inc. (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with an institutional investor (the “Investor”) under which the Company agreed to issue and sell, in a registered public offering, junior convertible notes (each, a “Note” and collectively, the “Notes”) for up to an aggregate principal amount of $5,555,555 (the “Notes”) that may be convertible into the Company’s ordinary shares, par value of $0.0001 per share (the “Ordinary Shares”).”
Debt Financings
Roadzen Inc. incurred convertible notes of up to an aggregate principal amount of $5,555,555 with an institutional investor at 14% per annum maturing June 20, 2027.
“agreed to issue and sell, in a registered public offering, junior convertible notes (each, a “Note” and collectively, the “Notes”) for up to an aggregate principal amount of $5,555,555 (the “Notes”) that may be convertible into the Company’s ordinary shares, par value of $0.0001 per share (the “Ordinary Shares”). The closing of the issuance and sale of the Notes”
Debt Financings
Roadzen Inc. incurred convertible notes of $5,555,555 with an institutional investor at 14% per annum (increasing to 18% per annum upon the occurrence and during the co maturing 18 months from the date of issuance.
“On November 20, 2025, Roadzen Inc. (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with an institutional investor (the “Investor”) under which the Company agreed to issue and sell, in a registered public offering, junior convertible notes (each, a “Note” and collectively, the “Notes”) for up to an aggregate principal amount of $5,555,555 (the “Notes”) that may be convertible into the Company’s ordinary shares, par value of $0.0001 per share (the “Ordinary Shares”).”
Xavier Blanchard resigned as Global Head of Strategy and Insurance at Roadzen Inc..
“The application confirms the resignation by Mr. Blanchard from his role as Global Head of Strategy and Insurance.”
Material Agreements
Roadzen Inc. entered into Securities Purchase Agreement with Supurna VedBrat and Krishnan-Shah Family Partners, LP valued at up to $2 million (effective 2024-03-28).
“on March 28, 2024, the Company entered into a Securities Purchase Agreement (the “SPA”) with Supurna VedBrat and Krishnan-Shah Family Partners, LP (together, the “Purchasers”), pursuant to which the Company agreed to issue and sell to the Purchasers, and the Purchasers agreed to purchase from the Company, an aggregate of up to $2 million in principal amount of senior secured notes (the “Notes”).”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.